CareDx
CDNA
19 hedge funds and large institutions have $33.5M invested in CareDx in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 6 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
7% less capital invested
Capital invested by funds: $36M → $33.5M (-$2.54M)
14% less funds holding
Funds holding: 22 → 19 (-3)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
GS
Gagnon Securities
New York
|
+$1.69M |
| 2 |
DM
Deerfield Management
New York
|
+$1.54M |
| 3 |
Goldman Sachs
New York
|
+$468K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$257K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$168K |
Top Sellers
CDNA Hedge Fund Activity: Q4 2014 in Review
19 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2014, worth a combined $33.5M — down 7.1% from $36M a quarter earlier.
Fund positioning in CDNA was balanced in Q4 2014: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was Gagnon Securities, adding an estimated $1.69M. The largest seller was Pine River Capital Management, exiting entirely with an estimated $1.78M sold.
- 19 institutional investors held CareDx (CDNA) as of Q4 2014, down from 22 in Q3 2014.
- Funds reported $33.5M of CareDx stock for Q4 2014, down 7.1% quarter-over-quarter.
- 6 funds opened new CareDx positions in Q4 2014 and 6 closed out, a net change of 0 holders.
- The largest CareDx buyer in Q4 2014 was Gagnon Securities, an estimated $1.69M added.
- The largest CareDx seller in Q4 2014 was Pine River Capital Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q4 2014.